|
| ID |
DDInter1733 |
| Drug Type |
small molecule |
| Molecular Formula |
C23H23Cln6O2 |
| Molecular Weight |
450.930
|
| Description |
Suvorexant is a orexin receptor antagonist used to treat insomnia that is characterized by difficulties with sleep onset and/or sleep maintenance.
|
| ATC Classification |
N05CM19
|
| IUPAC Name |
5-Chloro-2-[(5R)-5-Methyl-4-[5-Methyl-2-(2H-1,2,3-Triazol-2-Yl)Benzoyl]-1,4-Diazepan-1-Yl]-1,3-Benzoxazole |
| InChI |
Inchi=1S/C23H23Cln6O2/C1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/H3-6,8-9,13-14,16H,7,10-12H2,1-2H3/T16-/M1/S1 |
| InChI Key |
JYTNQNCOQXFQPK-MRXNPFEDSA-N |
| Canonical SMILES |
[H][C@@]1(C)CCN(CCN1C(=O)C1=C(C=CC(C)=C1)N1N=CC=N1)C1=NC2=C(O1)C=CC(Cl)=C2 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|